Metformin Use Was Associated With Reduced Risk of Incidental Sjogren's Syndrome in Patients With Type 2 Diabetes: A Population-Based Cohort Study

被引:9
|
作者
Wang, Cheng-You [1 ,2 ]
Lai, Jung-Nien [3 ,4 ]
Liu, Chin-Hsiu [5 ,6 ]
Hu, Kai-Chieh [6 ,7 ]
Sheu, Kai-Lun [2 ,8 ,9 ,10 ]
Wei, James Cheng-Chung [8 ,11 ,12 ]
机构
[1] E DA Hosp, Dept Med, Kaohsiung, Taiwan
[2] Chung Shan Med Univ, Sch Med, Taichung, Taiwan
[3] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan
[4] China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan
[5] China Med Univ Hosp, Rheumatol & Immunol Ctr, Taichung, Taiwan
[6] China Med Univ, Coll Med, Taichung, Taiwan
[7] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan
[8] Chung Shan Med Univ, Inst Med, Taichung, Taiwan
[9] Chung Shan Med Univ Hosp, Dept Family & Community Med, Taichung, Taiwan
[10] Chung Shan Med Univ Hosp, Dept Geriatr Med, Taichung, Taiwan
[11] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan
[12] Chung Shan Med Univ Hosp, Dept Rheumatol & Immunol, Taichung, Taiwan
关键词
metformin; Sjogren's syndrome; retrospective; cohort; National Health Insurance Research Database (NHIRD); INFLAMMATION; MANAGEMENT;
D O I
10.3389/fmed.2021.796615
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Previous studies have shown that metformin exhibits an anti-inflammatory effect and may decrease the risk of incidental diabetes. But the effect of metformin on incidental Sjogren's syndrome is unknown. The aim of the study was to examine the association between metformin exposure and Sjogren's syndrome in diabetic patients.Methods: The dataset in this retrospective cohort study was obtained from the National Health Insurance Research Database (2000-2013) in Taiwan. In total, 15,098 type 2 diabetic patients under metformin treatment and an equivalent number without metformin treatment matched for comparison were included. The primary endpoint was the incidence of Sjogren's syndrome. Univariate and multivariate Cox proportional hazards models were used for data analysis. A subgroup analysis and sensitivity test were also performed.Results: The incidence rate of Sjogren's syndrome in non-metformin controls was 40.83 per 100,000 person-years and 16.82 per 100,000 person-years in metformin users. The adjusted hazard ratio (aHR) in diabetic patients under metformin treatment was 0.46 (95% CI, 0.23 to 0.92). In subgroup analysis, men had a lower risk of developing Sjogren's syndrome than women [aHR = 0.15, 95% CI = (0.05, 0.41)]. After prescribing metformin to type 2 diabetic patients aged 60 years or more, those patients had a lower risk of developing Sjogren's syndrome [aHR = 0.34, 95% CI = (0.12, 0.96)].Conclusion: In this large population-based cohort study, metformin exposure was associated with a reduced risk of developing Sjogren's syndrome in type 2 diabetic patients.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Contraindications to metformin therapy in patients with Type 2 diabetes - a population-based study of adherence to prescribing guidelines
    Emslie-Smith, AM
    Boyle, DIR
    Evans, JMM
    Sullivan, F
    Morris, AD
    DIABETIC MEDICINE, 2001, 18 (06) : 483 - 488
  • [42] Lipid accumulation product and type 2 diabetes risk: a population-based study
    Sadafi, Sepehr
    Azizi, Ali
    Najafi, Farid
    Pasdar, Yahya
    BMC ENDOCRINE DISORDERS, 2024, 24 (01)
  • [43] Decreased risk of colorectal cancer among patients with type 2 diabetes receiving Chinese herbal medicine: a population-based cohort study
    Jhang, Jing-Siang
    Livneh, Hanoch
    Yang, Shu-Yi
    Huang, Hui-Ju
    Chan, Michael W. Y.
    Lu, Ming-Chi
    Yeh, Chia-Chou
    Tsai, Tzung-Yi
    BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
  • [44] Increased risk of acute coronary syndrome in patients with bronchiectasis: A population-based cohort study
    Hung, Chin-Tun
    Li, Shu-Fen
    Chung, Wei-Sheng
    RESPIROLOGY, 2018, 23 (09) : 828 - 834
  • [45] Metformin use in patients with type 2 diabetes mellitus is associated with reduced risk of deep vein thrombosis: a non-randomized, pair-matched cohort study
    Dai-Yin Lu
    Chin-Chou Huang
    Po-Hsun Huang
    Chia-Min Chung
    Shing-Jong Lin
    Jaw-Wen Chen
    Wan-Leong Chan
    Hsin-Bang Leu
    BMC Cardiovascular Disorders, 14
  • [46] Metformin use in patients with type 2 diabetes mellitus is associated with reduced risk of deep vein thrombosis: a non-randomized, pair-matched cohort study
    Lu, Dai-Yin
    Huang, Chin-Chou
    Huang, Po-Hsun
    Chung, Chia-Min
    Lin, Shing-Jong
    Chen, Jaw-Wen
    Chan, Wan-Leong
    Leu, Hsin-Bang
    BMC CARDIOVASCULAR DISORDERS, 2014, 14
  • [47] Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies
    Shang-Hung Chang
    Lung-Sheng Wu
    Meng-Jiun Chiou
    Jia-Rou Liu
    Kuang-Hui Yu
    Chang-Fu Kuo
    Ming-Shien Wen
    Wei-Jan Chen
    Yung-Hsin Yeh
    Lai-Chu See
    Cardiovascular Diabetology, 13
  • [48] Metformin and the risk of neurodegenerative diseases in patients with diabetes: A meta-analysis of population-based cohort studies
    Zhang, Yunnan
    Zhang, Yi
    Shi, Xiujin
    Han, Jialun
    Lin, Baidi
    Peng, Wenxing
    Mei, Zubing
    Lin, Yang
    DIABETIC MEDICINE, 2022, 39 (06)
  • [49] The Risk of Multiple Myeloma Is Reduced in Metformin Initiators: A Retrospective Cohort Study in Taiwanese Patients with Type 2 Diabetes Mellitus
    Tseng, Chin-Hsiao
    CANCERS, 2022, 14 (22)
  • [50] Association between incretin-based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: A large population-based matched cohort study
    Krishnan, Arunkumar
    Schneider, Carolin V.
    Arkenau, Hendrik-Tobias
    Mauro, Ezequiel Matias
    Forner, Alejandro
    Butsch, W. Scott
    Walsh, Declan
    Alqahtani, Saleh A.
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2024, 38